A compound of Formula (II): for use in the prevention or treatment of a bacterial infection.

##STR00001##

N.sup.2-phosphinyl amidine compounds, N.sup.2-phosphinyl amidinates, N.sup.2-phosphinyl amidine metal salt complexes, N.sup.2-phosphinyl amidinate metal salt complexes are described. Methods for making N.sup.2-phosphinyl amidine compounds, N.sup.2-phosphinyl amidinates, N.sup.2-phosphinyl amidine metal salt complexes, and N.sup.2-phosphinyl amidinate metal salt complexes are also disclosed. Catalyst systems utilizing the N.sup.2-phosphinyl amidine metal salt complexes and N.sup.2-phosphinyl amidinate metal salt complexes are also disclosed along with the use of the N.sup.2-phosphinyl amidine compounds, N.sup.2-phosphinyl amidinates, N.sup.2-phosphinyl amidine metal salt complexes, and N.sup.2-phosphinyl amidinate metal salt complexes for the oligomerization and/or polymerization of olefins.

The present invention relates to certain iron complexes that have utility in the field of catalytic hydrogenation and, more particularly, to certain iron complexes of tridentate ligands having one amino or imino coordinating groups and two phosphino coordinating groups. These iron complexes can be used in hydrogenation processes for the reduction of ketones, aldehydes, esters or lactones into the corresponding alcohol or diol, respectively.

The present application provides a secondary battery and an electrical apparatus containing the same. The secondary battery includes a positive electrode sheet, a negative electrode sheet, a separator disposed between the positive electrode sheet and the negative electrode sheet, and an electrolyte solution, wherein the separator includes a substrate and an inorganic and/or organic particle layer disposed on at least one surface of the substrate, and the separator further includes an acid scavenging additive located among the inorganic and/or organic particles of the inorganic and/or organic particle layer or located in a form of a separate layer between the substrate and the inorganic and/or organic particle layer, wherein the maximum dissolution amount of the acid scavenging additive in the electrolyte solution at 25? C. is less than 1% by mass relative to the mass of the electrolyte solution.

An electrolyte including at least a compound of formula I: ##STR00001##
A.sup.1, A.sup.2, and A.sup.3 are each independently selected from the following formulas I-A, I-B, I-C, or I-D, and the A.sup.1, A.sup.2, and A.sup.3 are not all I-A: ##STR00002##
m and k are 0 or 1, and n is integer from 1 to 6. R.sup.11, R.sup.13, R.sup.14, R.sup.15, R.sup.16, R.sup.17, R.sup.18, R.sup.19, R.sup.1a, R.sup.1b, R.sup.1c, and R.sup.1d are selected from hydrogen; substituted or unsubstituted C.sub.1-C.sub.10 alkylidene groups, C.sub.2-C.sub.10 alkenylene groups, C.sub.2-C.sub.10 alkynylidene groups, C.sub.3-C.sub.10 cumulative dienyl groups, C.sub.6-C.sub.10 aryl groups, or C.sub.3-C.sub.10 alicyclic hydrocarbon groups. R.sup.12 is selected from substituted or unsubstituted C.sub.1-C.sub.10 alkyl groups, C.sub.2-C.sub.10 alkenyl groups, C.sub.2-C.sub.10 alkynyl groups, C.sub.3-C.sub.10 cumulative dienyl groups, C.sub.6-C.sub.10 aryl groups, C.sub.3-C.sub.10 alicyclic hydrocarbon groups, or heteroatom-containing functional groups.

The present invention relates to the field of catalytic hydrogenation and, more particularly, to the use of Fe complexes with tridentate ligands, having one amino or imino coordinating group and two phosphino coordinating groups, in hydrogenation processes for the reduction of ketones, aldehydes, esters or lactones into the corresponding alcohol or diol, respectively. ##STR00001##

Disclosed herein are antibody-nanoparticle conjugates that include two or more nanoparticles (such as gold, palladium, platinum, silver, copper, nickel, cobalt, iridium, or an alloy of two or more thereof) directly linked to an antibody or fragment thereof through a metal-thiol bond. Methods of making the antibody-nanoparticle conjugates disclosed herein include reacting an arylphosphine-nanoparticle composite with a reduced antibody to produce an antibody-nanoparticle conjugate. Also disclosed herein are methods for detecting a target molecule in a sample that include using an antibody-nanoparticle conjugate (such as the antibody-nanoparticle conjugates described herein) and kits for detecting target molecules utilizing the methods disclosed herein.

N.sup.2-phosphinyl formamidine compounds and N.sup.2-phosphinyl formamidine metal salt complexes are described. Methods for making N.sup.2-phosphinyl formamidine compounds and N.sup.2-phosphinyl formamidine metal salt complexes are also disclosed. Catalyst systems utilizing the N.sup.2-phosphinyl formamidine metal salt complexes are also disclosed along with the use of the N.sup.2-phosphinyl amidine compounds and N.sup.2-phosphinyl amidinate metal salt complexes for the oligomerization and/or polymerization of olefins.

The present invention relates to a process for preparing substituted biphenylanilides of the formula (I)

##STR00001##

in which R.sup.1 is selected from a protected amino group, NO.sub.2, NH.sub.2 and NHR.sup.3,
in which a compound of the formula II

##STR00002##

is reacted in the presence of a base and of a palladium salt, in the presence of a phosphine ligand of the formula (V) as complex ligand

##STR00003##

or a salt thereof, in a solvent, with an organoboron compound of the formula (III)

##STR00004##

in which all the substituents are as defined in the description.

The present invention relates to a process for preparing substituted biphenylanilides of the formula (I). ##STR00001##